Audit of failed immunohistochemical slides in the clinical laboratory: the role of on-slide controls
- CC Cheung, CR Taylor, EE. Torlakovics
- Appl Immunohistochem Mol Morphol
The activities of ISIMM (The International Society for Immunohistochemistry and Molecular Morphology) in its foundation year were reviewed by members gathered together at USCAP (United States and Canadian Academy of Pathology) in San Antonio, Texas, in Spring 2017, immediately following the meeting of the Editorial Board of AIMM (Applied Immunohistochemistry and Molecular Morphology). The close affiliation of ISIMM and AIMM is reflected in the “Control Series” and “Evolution Series” of papers published in AIMM over the past several months, with a focus on improved quality of immunohistochemistry through improved and standardized approaches to selection of control materials. This series follows directly from the 2 earlier papers on the use of positive and negative controls. The society website (www.isimm.org) is live with information about the Society and is showing encouraging activity. Of the several planned ISIMM-sponsored workshops, 2 have already taken place. The first workshop was in conjunction with the Asian Pacific International Academy of Pathology, in Bali, Indonesia, in April, with a focus on Quality Control, Diagnostic Panels, and Companion Diagnostics, presented by Mogens Vyberg, Blake Gilks, Allen Gown, and Clive Taylor. These presentations are being made available to members on the ISIMM website. The second workshop was sponsored by NordiQC in Aalborg, Denmark, in June, with participation by ISIMM members; presentations may be found on the NordiQC conference website (www.nordiqc2017. dk). A third ISIMM workshop organized by Blake Gilks will take place at the Annual American Society of Clinical Pathology (ASCP) meeting in Chicago from September 6-7, 2017, with the title “Real World Immunohistochemistry: What You Need To Know to Successfully Employ It.” The planned program is as follows: “Companion Diagnostics and Personalized Medicine” (C Taylor); “Choice of controls for Immunohistochemistry” (S Nielsen: NordiQC); “Evolution of Quality Assurance for Diagnostic Immunohistochemistry: Validation of New Immunohistochemical Tests” (E Torlakovic: Canadian Immunohistochemistry QC); and “Rational and Effective Use of Antibody Panels” (A Gown).